Vaginal Oestrogen Therapy for Postmenopausal Women Undergoing Prolapse Surgery: A Multicentre Double‐Blind Randomised Placebo‐Controlled Clinical Trial

{"OBJECTIVE:":[0],"To":[1],"determine":[2],"whether":[3],"vaginal":[4,51,202,224],"oestrogen":[5,117,143,203,225],"therapy":[6],"improves":[7],"outcomes":[8,206],"after":[9],"prolapse":[10,43,77,239],"surgery":[11],"in":[12,28,76,115,121,141,231],"postmenopausal":[13,235],"women.":[14],"DESIGN:":[15],"Double-blind,":[16],"randomised,":[17],"placebo-controlled":[18],"trial":[19],"with":[20,34,234],"12":[21,66,80,110,214],"month":[22],"follow-up.":[23],"SETTING:":[24],"Multicentre,":[25],"22":[26],"hospitals":[27],"the":[29,91,116,122,128,142],"Netherlands.":[30],"POPULATION:":[31],"Postmenopausal":[32],"women":[33,103,106,114,156,236],"POP-Q":[35],"stage":[36],"≥":[37],"2":[38],"scheduled":[39],"for":[40,191],"primary":[41,238],"native-tissue":[42],"repair.":[44],"METHODS:":[45],"Women":[46],"were":[47],"randomised":[48],"(1:1)":[49],"to":[50,65,185],"oestriol":[52],"cream":[53,182],"(1":[54],"mg/g)":[55],"or":[56,86],"identical":[57],"placebo,":[58],"started":[59],"4-6":[60],"weeks":[61],"preoperatively":[62],"and":[63,154,173,207],"continued":[64],"months":[67,81],"postoperatively":[68],"(twice-weekly":[69],"maintenance).":[70],"MAIN":[71],"OUTCOME":[72],"MEASURE:":[73],"Subjective":[74],"improvement":[75,126],"symptoms":[78],"at":[79,213],"postoperatively,":[82],"defined":[83],"as":[84,226],"\\"much\\"":[85],"\\"very":[87],"much\\"":[88],"improved":[89,204],"on":[90,127],"Patient":[92],"Global":[93],"Impression":[94],"of":[95,113,137,211],"Improvement":[96],"(PGI-I)":[97],"scale.":[98],"RESULTS:":[99],"In":[100],"total":[101],"293":[102],"participated,":[104],"57":[105],"dropped":[107],"out.":[108],"At":[109],"months,":[111,215],"92%":[112],"group":[118,124,144],"versus":[119],"80%":[120,187],"placebo":[123],"reported":[125,157],"PGI-I":[129],"scale":[130],"(p":[131],"=":[132,152,164],"0.02).":[133],"Pelvic":[134],"floor-related":[135,209],"quality":[136,210],"life":[138,212],"was":[139,183],"better":[140],"(median":[145],"score":[146],"PFDI-20:":[147],"17":[148],"vs.":[149,161],"25,":[150],"p":[151,163],"0.03),":[153],"fewer":[155],"discomfort/pain":[158],"(EQ-5D-5L:":[159],"61%":[160],"77%,":[162],"0.04).":[165],"Anatomical":[166],"outcomes,":[167],"composite":[168],"surgical":[169],"success,":[170],"sexual":[171],"function":[172],"reintervention":[174],"rates":[175],"did":[176],"not":[177],"differ":[178],"between":[179],"groups.":[180],"The":[181],"easy":[184],"use;":[186],"would":[188],"use":[189],"it":[190,195],"1":[192],"year":[193],"if":[194],"provided":[196],"meaningful":[197],"health":[198],"benefits.":[199],"CONCLUSIONS:":[200],"Perioperative":[201],"patient-reported":[205],"pelvic":[208],"without":[216],"affecting":[217],"anatomical":[218],"outcomes.":[219],"These":[220],"findings":[221],"support":[222],"discussing":[223],"an":[227],"adjunctive":[228],"treatment":[229],"option":[230],"shared":[232],"decision-making":[233],"undergoing":[237],"surgery.":[240],"TRIAL":[241],"REGISTRATION:":[242],"NL-OMON55535,":[243],"https://www.onderzoekmetmensen.nl/en/trial/55535.":[244]}